Abstract
Many of the proteins involved in meiotic recombination are conserved among eukaryotes, and here we discuss those recombination proteins that have been identified in plants. In addition, we summarize some of the differences in crossover regulation between plants and budding yeast (the primary model for molecular studies of recombination in eukaryotes). We also discuss factors that influence the distribution of crossovers including chromosome, chromatin and genomic structure. Different methods have been used for mapping recombination in plants including genetic linkage maps, cytogenetic maps (e.g., chiasmata and recombination nodules), and physical maps (DNA sequence and contigs). Progress has been made in integrating the different types of maps to provide a more complete understanding of genome structure and function in plants, including the control of meiotic recombination.
Current Genomics
Title: Meiotic Recombination in Plants
Volume: 3 Issue: 6
Author(s): L. K. Anderson and S. M. Stack
Affiliation:
Abstract: Many of the proteins involved in meiotic recombination are conserved among eukaryotes, and here we discuss those recombination proteins that have been identified in plants. In addition, we summarize some of the differences in crossover regulation between plants and budding yeast (the primary model for molecular studies of recombination in eukaryotes). We also discuss factors that influence the distribution of crossovers including chromosome, chromatin and genomic structure. Different methods have been used for mapping recombination in plants including genetic linkage maps, cytogenetic maps (e.g., chiasmata and recombination nodules), and physical maps (DNA sequence and contigs). Progress has been made in integrating the different types of maps to provide a more complete understanding of genome structure and function in plants, including the control of meiotic recombination.
Export Options
About this article
Cite this article as:
Anderson K. L. and Stack M. S., Meiotic Recombination in Plants, Current Genomics 2002; 3 (6) . https://dx.doi.org/10.2174/1389202023350200
DOI https://dx.doi.org/10.2174/1389202023350200 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hepatitis C Treatment in Patients with Drug Addiction: Clinical Management of Interferon-Alpha-Associated Psychiatric Side Effects
Current Drug Abuse Reviews Global Life-Long Health Benefits of Repression of Hypothalamic NPY System by Central Leptin Gene Therapy
Current Topics in Medicinal Chemistry Mitochondrial, Metabolic and Genotoxic Effects of Antiretroviral Nucleoside Reverse-Transcriptase Inhibitors
Anti-Infective Agents in Medicinal Chemistry Neurotrophic Factors as a Protective Strategy in Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Metformin - The Drug for the Treatment of Autoimmune Diseases; A New Use of a Known Anti-Diabetic Drug
Current Topics in Medicinal Chemistry Binding Modes and Pharmacophore Modelling of Thermolysin Inhibitors
Mini-Reviews in Medicinal Chemistry The Renin-Angiotensin System: Emerging Concepts
Current Hypertension Reviews Cancer Stem Cells in Solid and Liquid Tissues of Breast Cancer Patients: Characterization and Therapeutic Perspectives
Current Cancer Drug Targets Toxics of Tobacco Smoke and Cardiovascular System: From Functional to Cellular Damage
Current Pharmaceutical Design Menstrual Disorders Related to Eating Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets HSV Amplicons: Neuro Applications
Current Gene Therapy Cognitive - Behavioral Therapy in Central Sensitivity Syndromes
Current Rheumatology Reviews The Potential Therapeutic Value of Renin-Angiotensin System Inhibitors in the Treatment of Colorectal Cancer
Current Pharmaceutical Design Cardiac Effects of HDL and Its Components on Diabetic Cardiomyopathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Commercially Available, FDA-approved Epigenetic Modifiers As Therapeutic Agents in Bacterial Infection
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice
Current Clinical Pharmacology Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
Current Drug Targets Pulmonary Involvement in Inflammatory Bowel Disease
Current Drug Targets - Inflammation & Allergy Jun Dimerization Protein 2 in Oxygen Restriction; Control of Senescence
Current Pharmaceutical Design